Hematopoietic stem cell transplantation
Therapy improves stem cell engraftment in umbilical cord blood transplant recipients
A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases, a phase I clinical trial led by Dana-Farber Cancer…
Family or no, marrow, blood stem cell transplant survival rates equal
Patients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likely to have graft failure but less likely to experience graft-versus-host disease, a condition caused…